Innovus Pharmaceuticals Inc. (fka INNV)

[florida investor]

I'm going to tell you why you are wrong, shorting the stock will mean decreasing the market cap of the company, it's already at 16 million with sales of 25M, with a very high chance of just one product ( fluticare) of surpassing the market cap in sales all by it self. Something else we need to think is usually the market adjusts pre R/S and I think we already did, there is no way this company is worth less with 25M in sales than it was with 8.8M and that's the reason the new investor decided to jump in claiming they saw an opportunity because they believe INNV is very undervalued.